| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| V Lerner, B Chudakova, S Kravets, I Polyakov. Combined use of risperidone and olanzapine in the treatment of patients with resistant schizophrenia: a preliminary case series report. Clinical neuropharmacology. vol 23. issue 5. 2001-03-08. PMID:11154098. |
combined use of risperidone and olanzapine in the treatment of patients with resistant schizophrenia: a preliminary case series report. |
2001-03-08 |
2023-08-12 |
Not clear |
| E Spina, M G Scordo, A Avenoso, E Perucc. Adverse drug interaction between risperidone and carbamazepine in a patient with chronic schizophrenia and deficient CYP2D6 activity. Journal of clinical psychopharmacology. vol 21. issue 1. 2001-03-01. PMID:11199933. |
adverse drug interaction between risperidone and carbamazepine in a patient with chronic schizophrenia and deficient cyp2d6 activity. |
2001-03-01 |
2023-08-12 |
Not clear |
| K Wahlbeck, M Cheine, K Tuisku, A Ahokas, G Joffe, R Rimó. Risperidone versus clozapine in treatment-resistant schizophrenia: a randomized pilot study. Progress in neuro-psychopharmacology & biological psychiatry. vol 24. issue 6. 2001-02-08. PMID:11041534. |
risperidone versus clozapine in treatment-resistant schizophrenia: a randomized pilot study. |
2001-02-08 |
2023-08-12 |
human |
| K Wahlbeck, M Cheine, K Tuisku, A Ahokas, G Joffe, R Rimó. Risperidone versus clozapine in treatment-resistant schizophrenia: a randomized pilot study. Progress in neuro-psychopharmacology & biological psychiatry. vol 24. issue 6. 2001-02-08. PMID:11041534. |
the atypical antipsychotic risperidone may constitute an alternative to clozapine, the current treatment of choice for refractory schizophrenia. |
2001-02-08 |
2023-08-12 |
human |
| S R David, C C Taylor, B J Kinon, A Breie. The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia. Clinical therapeutics. vol 22. issue 9. 2001-02-01. PMID:11048906. |
the effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia. |
2001-02-01 |
2023-08-12 |
Not clear |
| J P Lindenmaye. Treatment refractory schizophrenia. The Psychiatric quarterly. vol 71. issue 4. 2001-01-18. PMID:11025914. |
the effects of the atypicals clozapine, olanzapine, risperidone and quetiapine as compared to typicals are reviewed using available double-blind studies in this treatment refractory group of schizophrenia patients. |
2001-01-18 |
2023-08-12 |
Not clear |
| A Fink-Jense. Novel pharmacological approaches to the treatment of schizophrenia. Danish medical bulletin. vol 47. issue 3. 2000-11-30. PMID:10913983. |
these results are in accordance with the reported beneficial effects of clozapine, risperidone and sertindole on negative symptoms of schizophrenia and their lower degree of motoric side effects compared to haloperidol. |
2000-11-30 |
2023-08-12 |
human |
| A Fink-Jense. Novel pharmacological approaches to the treatment of schizophrenia. Danish medical bulletin. vol 47. issue 3. 2000-11-30. PMID:10913983. |
also these results are in concordance with the clinical effects of clozapine, risperidone, sertindole and haloperidol and support the hypothesis that reduced dopaminergic tone in the prefrontal cortex relates to the negative symptoms of schizophrenia. |
2000-11-30 |
2023-08-12 |
human |
| N Bhana, C M Spence. Risperidone: a review of its use in the management of the behavioural and psychological symptoms of dementia. Drugs & aging. vol 16. issue 6. 2000-11-30. PMID:10939309. |
risperidone is a benzisoxazole derivative which has proven efficacy against the positive and negative symptoms of schizophrenia. |
2000-11-30 |
2023-08-12 |
Not clear |
| R Yoshimura, J Nakamura, N Ueda, T Tera. Effect of risperidone on plasma free 3-methoxy-4-hydroxyphenylglycol (pMHPG) levels in schizophrenic patients: relationship among plasma concentrations of risperidone and 9-hydroxyrisperidone, pMHPG levels, and clinical improvement. International clinical psychopharmacology. vol 15. issue 3. 2000-11-28. PMID:10870876. |
clinical improvement in negative symptoms of schizophrenia treated with risperidone has been associated with increased pmhpg and, in the present study, there were positive correlations between plasma 9-hydroxyrisperidone concentrations and increased pmhpg levels. |
2000-11-28 |
2023-08-12 |
Not clear |
| R Yoshimura, J Nakamura, N Ueda, T Tera. Effect of risperidone on plasma free 3-methoxy-4-hydroxyphenylglycol (pMHPG) levels in schizophrenic patients: relationship among plasma concentrations of risperidone and 9-hydroxyrisperidone, pMHPG levels, and clinical improvement. International clinical psychopharmacology. vol 15. issue 3. 2000-11-28. PMID:10870876. |
these results suggest that risperidone might improve negative symptoms in schizophrenia by influencing noradrenergic neurons. |
2000-11-28 |
2023-08-12 |
Not clear |
| M Z Azha. Comparison of risperidone and other neuroleptics in the management of chronic schizophrenia using cognitive therapy. The Medical journal of Malaysia. vol 55. issue 1. 2000-11-21. PMID:11072484. |
comparison of risperidone and other neuroleptics in the management of chronic schizophrenia using cognitive therapy. |
2000-11-21 |
2023-08-12 |
Not clear |
| A Adesanya, C Panteli. Adjunctive risperidone treatment in patients with 'clozapine-resistant schizophrenia'. The Australian and New Zealand journal of psychiatry. vol 34. issue 3. 2000-11-20. PMID:10881988. |
adjunctive risperidone treatment in patients with 'clozapine-resistant schizophrenia'. |
2000-11-20 |
2023-08-12 |
Not clear |
| S Bleich, D Degner, S Kropp, G Hajak, E Rüthe. Risperidone in disorganised schizophrenia. The Australian and New Zealand journal of psychiatry. vol 34. issue 3. 2000-11-20. PMID:10881990. |
risperidone in disorganised schizophrenia. |
2000-11-20 |
2023-08-12 |
Not clear |
| K Antoniou, S Bekris, M Saranti, P Stathis, M Rimikis, Z Papadopoulou-Daifot. The effects of antipsychotic drugs on serotonergic activity in the rat hippocampus. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 10. issue 5. 2000-10-30. PMID:10974601. |
moreover, the augmentation of serotonergic activity induced by risperidone did not seem to be solely related to dopaminergic or serotonergic properties and may be of particular relevance for the amelioration of schizophrenia symptoms. |
2000-10-30 |
2023-08-12 |
rat |
| J A Sacristán, J C Gómez, A L Montejo, E Vieta, K J Grego. Doses of olanzapine, risperidone, and haloperidol used in clinical practice: results of a prospective pharmacoepidemiologic study. EFESO Study Group. Estudio Farmacoepidemiologico en la Esquizofrenia con Olanzapina. Clinical therapeutics. vol 22. issue 5. 2000-10-12. PMID:10868556. |
the objectives of this study were to determine the doses of olanzapine (olz), risperidone (ris), and haloperidol (hal) used in clinical practice in outpatients with schizophrenia and the rates of occurrence of extrapyramidal symptoms (eps) and other adverse events, clinical response, and use of concomitant medications. |
2000-10-12 |
2023-08-12 |
Not clear |
| M Davidson, P D Harvey, J Vervarcke, C A Gagiano, J D De Hooge, G Bray, M Dose, Y Barak, M Haushofe. A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis. On behalf of the Risperidone Working Group. International journal of geriatric psychiatry. vol 15. issue 6. 2000-09-19. PMID:10861916. |
studies have shown that risperidone is safe and efficacious in young and middle-aged adults with chronic schizophrenia, but considerably fewer data are available on the treatment of elderly patients with schizophrenia or other psychotic disorders, particularly long-term outcomes. |
2000-09-19 |
2023-08-12 |
Not clear |
| L C Kopala, C Caudl. Acute and longer-term effects of risperidone in a case of first-episode catatonic schizophrenia. Journal of psychopharmacology (Oxford, England). vol 12. issue 3. 2000-09-15. PMID:10958259. |
acute and longer-term effects of risperidone in a case of first-episode catatonic schizophrenia. |
2000-09-15 |
2023-08-12 |
Not clear |
| L C Kopala, C Caudl. Acute and longer-term effects of risperidone in a case of first-episode catatonic schizophrenia. Journal of psychopharmacology (Oxford, England). vol 12. issue 3. 2000-09-15. PMID:10958259. |
this case report documents the response of a young, first-episode, neuroleptic naive male with severe catatonic schizophrenia to the novel antipsychotic, risperidone. |
2000-09-15 |
2023-08-12 |
Not clear |
| L C Kopala, C Caudl. Acute and longer-term effects of risperidone in a case of first-episode catatonic schizophrenia. Journal of psychopharmacology (Oxford, England). vol 12. issue 3. 2000-09-15. PMID:10958259. |
no other literature on the effect of risperidone in the treatment of severe catatonic schizophrenia in a first-episode patient has been reported. |
2000-09-15 |
2023-08-12 |
Not clear |